Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/01/25
End: 06/15/26
Due: 06/15/27
Phase: N/A
Priority: Normal
Start: 11/21/23
End: 09/02/25
Due: 09/02/26
Phase: N/A
Priority: Normal
Start: 03/13/24
End: 10/31/25
Due: 10/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus | NCT06340750 | Luminary Therapeutics | user2@example.com | None | 2025-04-01 | 2026-06-15 | 2027-06-15 | - | - | 2025-07-14 |
| Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma | NCT05312801 | Luminary Therapeutics | user2@example.com | None | 2023-11-21 | 2025-09-02 | 2026-09-02 | - | - | 2025-07-14 |
| LMY-920 for Treatment of Relapsed or Refractory Myeloma | NCT05546723 | Luminary Therapeutics | user2@example.com | None | 2024-03-13 | 2025-10-31 | 2026-10-31 | - | - | 2025-07-14 |